Worldwide Assessment of Linezolid's Clinical Safety and Tolerability: Comparator-Controlled Phase III Studies

Linezolid, an oxazolidinone antibiotic, has 100% oral bioavailability and favorable activities against gram-positive pathogens including multidrug-resistant staphylococci, enterococci, and pneumococci. Safety assessments were conducted for 2,046 linezolid-treated patients and 2,001 comparator drug-t...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Rubinstein, Ethan, Isturiz, Raul, Standiford, Harold C., Smith, Leon G., Oliphant, Thomas H., Cammarata, Sue, Hafkin, Barry, Le, Vu, Remington, Jack
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2003
Aiheet:
Clinical Therapeutics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC155822/
https://ncbi.nlm.nih.gov/pubmed/12760854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.6.1824-1831.2003
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia